Cite
HARVARD Citation
Dulai, P. et al. (n.d.). P413 A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn's disease. Journal of Crohn's and colitis. p. S316. [Online].